Hurd Andrew 4
4 · EPOCRATES INC · Filed Mar 13, 2013
Insider Transaction Report
Form 4
EPOCRATES INCEPOC
Hurd Andrew
President and CEO
Transactions
- Disposition to Issuer
Common Stock
2013-03-12−140,877→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2013-03-12−59,010→ 0 totalExercise: $8.46→ Common Stock (59,100 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-03-12−740,900→ 0 totalExercise: $8.46→ Common Stock (740,900 underlying)
Footnotes (4)
- [F1]Pursuant to the Agreement and Plan of Merger among Epocrates, Inc. (the "Issuer"), athenahealth, Inc. ("athenahealth"), and Echo Merger Sub, Inc., a wholly-owned subsidiary of athenahealth, dated January 7, 2013 (the "Merger Agreement"), each share of the Issuer's common stock was exchanged for $11.75 in cash, without interest and less any applicable withholding taxes (the "Merger").
- [F2]Includes shares of restricted stock units that accelerated and became fully vested as of the closing of the Merger.
- [F3]All stock options under this award accelerated and became fully vested as of the closing of the Merger.
- [F4]In connection with the Merger, the vested and/or exercisable portion of each Issuer stock option held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of the number of shares issuable upon the exercise of such option and $11.75 minus the exercise price of such option. The Reporting Person's options, if any, with an exercise price equal to or above $11.75 were canceled in connection with the Merger.